The prevalence of hepatitis C and hepatitis G virus infection in patients with B cell non-Hodgkin lymphomas in Greece: a Hellenic Cooperative Oncology Group Study

Acta Haematol. 2004;112(4):189-93. doi: 10.1159/000081270.

Abstract

Our aim was to investigate the association between chronic hepatitis C virus (HCV) infection and B cell non-Hodgkin lymphoma (NHL) in the Greek population. We studied 120 patients (70 men and 50 women, mean age 59 years) diagnosed with NHL. One hundred and eight had B cell NHL (90%) and 12 had T cell NHL (10%). The presence of anti-HCV antibodies in patients and controls was investigated using the monoclonal enzymatic immunoassay (MEIA) method. The detection of HCV RNA and hepatitis G virus (HGV) RNA in patients with B cell NHL and anti-HCV-positive controls was performed using an RT-PCR technique. Anti-HCV antibodies were present in only 2 of the 108 patients with B cell NHL (1.9%), while the prevalence of HCV infection in the healthy population was 0.6%, and in patients with various solid tumors treated with chemotherapy, it was 0.99%. Ten of the 108 B cell NHL patients (9.26%) were diagnosed as HGV RNA positive, while the prevalence of HGV infection in 285 Greek blood donors was 0.7%. Our findings do not confirm a strong association between HCV infection and B cell NHL for Greek patients. The increased prevalence of HGV infection detected in patients with NHL could imply the potential participation of HGV in the pathogenesis of NHL.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Viral / blood
  • Case-Control Studies
  • Female
  • Flaviviridae Infections / complications*
  • Flaviviridae Infections / epidemiology
  • GB virus C*
  • Greece / epidemiology
  • Hepatitis C / complications*
  • Hepatitis C / epidemiology
  • Hepatitis, Viral, Human / complications*
  • Hepatitis, Viral, Human / epidemiology
  • Humans
  • Lymphoma, B-Cell / epidemiology
  • Lymphoma, B-Cell / etiology
  • Lymphoma, B-Cell / virology*
  • Male
  • Middle Aged
  • Prevalence
  • RNA, Viral / blood

Substances

  • Antibodies, Viral
  • RNA, Viral